|View printer-friendly version|
|Lubrizol LifeSciences to Showcase Expanded Medical Device Solutions at Medtec EU 2016|
The Lubrizol Corporation
29400 Lakeland Blvd, Wickliffe, Ohio 44092-2298
Lubrizol LifeSciences to Showcase Expanded
CLEVELAND, April 12, 2016 -The Lubrizol Corporation's LifeSciences business will showcase its total solution capabilities at Medtec Europe 2016, Booth #5A65, April 12-14 at Messe Stuttgart in Stuttgart, Germany. LifeSciences will also co-exhibit resins at the event with Velox GmbH, a leading European supplier of specialty raw materials, at Booth #3F20. Lubrizol LifeSciences is a healthcare solution partner for medical device manufacturers who need product development support and drug eluting device solutions. LifeSciences, with the addition of Particle Sciences and Vesta capabilities, is positioned as the only healthcare product solution partner offering polymer customization, complex drug formulation and contract manufacturing solutions.
LifeSciences' offers custom medical device contract manufacturing services specializing in comprehensive silicone device fabrication along with precision thermoplastic extrusion and secondary operations. With over four decades of experience, the company's service, engineering expertise and commitment to quality are sought by customers worldwide. Vesta's combined team works together to care for the life of customer products.
"We have significantly enhanced our capabilities through the combination of strong polymer technology, application know-how and world-class component manufacturing," states Deb Langer, vice president and general manager, Lubrizol LifeSciences. "As healthcare companies look for total solution providers, we continue to focus on the right areas in order to provide valuable offerings to our customers."
To show their commitment to the medical device market, LifeSciences is investing more than $15 million to expand its global development and manufacturing facilities, positioning Lubrizol to better serve the growing market for medical device development and contract manufacturing. This capital investment will expand multiple facilities and increase Lubrizol LifeSciences' in-house engineering capacity for both silicone and thermoplastic products. Part of this investment expands their thermoplastic capabilities to include: tip forming, tube flaring, pad printing, hole punching/drilling, precision cutting, reflow, braided tubing lamination and more.
"When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process," states Robert Miller, global business director, medical devices. "With a long history of polymer expertise and significant investment, Lubrizol LifeSciences is positioned to offer end-to-end development for next generation medical and pharmaceutical innovations."
- more -
Particle Sciences and Vesta are part of Lubrizol Advanced Materials Inc.
About The Lubrizol Corporation
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.